Abstract
Objectives
We evaluated healthcare cost differences at the end of life (EOL) between language regions in Switzerland, accounting for a comprehensive set of variables, including treatment intensity.
Methods
We evaluated 9716 elderly who died in 2014 and were insured at Helsana Group, with data on final cause of death provided by the Swiss Federal Statistical Office. EOL healthcare costs and utilization, ≥ 1 ICU admission and 10 life-sustaining interventions (cardiac catheterization, cardiac assistance device implantation, pulmonary artery wedge monitoring, cardiopulmonary resuscitation, gastrostomy, blood transfusion, dialysis, mechanical ventilation, intravenous antibiotics, cancer chemotherapies) reimbursed by compulsory insurance were examined.
Results
Taking into consideration numerous variables, relative cost differences decreased from 1.27 (95% CI 1.19–1.34) to 1.06 (CI 1.02–1.11) between the French- and German-speaking regions, and from 1.12 (CI 1.03–1.22) to 1.08 (CI 1.02–1.14) between the Italian- and German-speaking regions, but standardized costs still differed. Contrary to individual factors, density of home-care nurses, treatment intensity, and length of inpatient stay explain a substantial part of these differences.
Conclusions
Both supply factors and health-service provision at the EOL vary between Swiss language regions and explain a substantial proportion of cost differences.
Similar content being viewed by others
References
Bähler C, Signorell A, Reich O (2016) Health care utilisation and transitions between health care settings in the last 6 months of life in Switzerland. PLoS ONE 11:e0160932. https://doi.org/10.1371/journal.pone.0160932
Bähler C, Signorell A, Blozik E, Reich O (2018) Intensity of treatment in Swiss cancer patients at the end-of-life. CMAR 10:481–491. https://doi.org/10.2147/CMAR.S156566
Barnato AE, Farrell MH, Chang C-CH, Lave JR, Roberts MS, Angus DC (2009) Development and validation of hospital “end-of-life” treatment intensity measures. Med Care 47:1098–1105. https://doi.org/10.1097/MLR.0b013e3181993191
Borasio GD, Jox RJ (2016) Choosing wisely at the end of life: the crucial role of medical indication. Swiss Med Wkly 146:w14369. https://doi.org/10.4414/smw.2016.14369
Boumendil A, Angus DC, Guitonneau A-L, Menn A-M, Ginsburg C, Takun K, Davido A, Masmoudi R, Doumenc B, Pateron D, Garrouste-Orgeas M, Somme D, Simon T, Aegerter P, Guidet B (2012) Variability of intensive care admission decisions for the very elderly. PLoS ONE 7:e34387. https://doi.org/10.1371/journal.pone.0034387
Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, Nagpal S, Saini V, Srivastava D, Chalmers K, Korenstein D (2017) Evidence for overuse of medical services around the world. Lancet (London, England) 390:156–168. https://doi.org/10.1016/S0140-6736(16)32585-5
Busato A, Künzi B (2008) Primary care physician supply and other key determinants of health care utilisation: the case of Switzerland. BMC Health Serv Res 8:8. https://doi.org/10.1186/1472-6963-8-8
Chini F, Giorgi Rossi P, Costantini M, Beccaro M, Borgia P (2010) Validity of caregiver-reported hospital admission in a study on the quality of care received by terminally ill cancer patients. J Clin Epidemiol 63:103–108. https://doi.org/10.1016/j.jclinepi.2009.02.006
Costa-Font J, Jimenez-Martin S, Vilaplana C (2018) Does long-term care subsidization reduce hospital admissions and utilization? J Health Econ 58:43–66. https://doi.org/10.1016/j.jhealeco.2018.01.002
de Pietro C, Camenzind P, Sturny I, Crivelli L, Edwards-Garavoglia S, Spranger A, Wittenbecher F, Quentin W (2015) Switzerland: health system review. Health Syst Transit 17(1–288):xix
Detering KM, Hancock AD, Reade MC, Silvester W (2010) The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 340:c1345
Eichler K, Hess S, Chmiel C, Bögli K, Sidler P, Senn O, Rosemann T, Brügger U (2014) Sustained health-economic effects after reorganisation of a Swiss hospital emergency centre: a cost comparison study. Emerg Med J 31:818–823. https://doi.org/10.1136/emermed-2013-202760
Faeh D, Bopp M (2010) Educational inequalities in mortality and associated risk factors: German–versus French-speaking Switzerland. BMC Public Health 10:567. https://doi.org/10.1186/1471-2458-10-567
Faeh D, Minder C, Gutzwiller F, Bopp M (2009) Culture, risk factors and mortality: can Switzerland add missing pieces to the European puzzle? J Epidemiol Community Health 63:639–645. https://doi.org/10.1136/jech.2008.081042
Flaatten H, de Lange DW, Artigas A, Bin D, Moreno R, Christensen S, Joynt GM, Bagshaw SM, Sprung CL, Benoit D, Soares M, Guidet B (2017) The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Med. https://doi.org/10.1007/s00134-017-4718-z
Gielen B, Remacle A, Mertens R (2010) Patterns of health care use and expenditure during the last 6 months of life in Belgium: differences between age categories in cancer and non-cancer patients. Health Policy 97:53–61
Gruneir A, Mor V, Weitzen S, Truchil R, Teno J, Roy J (2007) Where people die: a multilevel approach to understanding influences on site of death in America. Med Care Res Rev 64:351–378. https://doi.org/10.1177/1077558707301810
Guidet B, Leblanc G, Simon T, Woimant M, Quenot J-P, Ganansia O, Maignan M, Yordanov Y, Delerme S, Doumenc B, Fartoukh M, Charestan P, Trognon P, Galichon B, Javaud N, Patzak A, Garrouste-Orgeas M, Thomas C, Azerad S, Pateron D, Boumendil A (2017) Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in France: a randomized clinical trial. JAMA 318:1450–1459. https://doi.org/10.1001/jama.2017.13889
Hanchate A, Kronman AC, Young-Xu Y, Ash AS, Emanuel EJ (2009) Racial and ethnic differences in end-of-life costs: Why do minorities cost more than whites? Arch Internal Med 169:493–501. https://doi.org/10.1001/archinternmed.2008.616
Hedinger D, Braun J, Zellweger U, Kaplan V, Bopp M (2014) Moving to and dying in a nursing home depends not only on health—an analysis of socio-demographic determinants of place of death in Switzerland. PLoS ONE 9:e113236
Hedinger D, Hammig O, Bopp M (2015) Social determinants of duration of last nursing home stay at the end of life in Switzerland: a retrospective cohort study. BMC Geriatr 15:114
Huber CA, Szucs TD, Rapold R, Reich O (2013) Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 13:1030. https://doi.org/10.1186/1471-2458-13-1030
Jena AB, Olenski AR, Khullar D, Bonica A, Rosenthal H (2018) Physicians’ political preferences and the delivery of end of life care in the United States: retrospective observational study. BMJ 361:k1161
Kronman AC, Ash AS, Freund KM, Hanchate A, Emanuel EJ (2008) Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med 23:1330–1335. https://doi.org/10.1007/s11606-008-0638-5
Kwok AC, Semel ME, Lipsitz SR, Bader AM, Barnato AE, Gawande AA, Jha AK (2011) The intensity and variation of surgical care at the end of life: a retrospective cohort study. Lancet (London, England) 378:1408–1413. https://doi.org/10.1016/S0140-6736(11)61268-3
Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Konzelmann I, Mousavi M, Clough-Gorr KM, Szucs TD, Schwenkglenks M, Pestalozzi BC (2016) Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09). Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.12453
Menec V, Lix L, Steinbach C, Ekuma O, Sirski M, Dahl M, Soodeen R (2004) Patterns of health care use and cost at the end of life. University of Manitoba. ISBN 1-896489-18-4. http://www.umanitoba.ca/centres/mchp/reports.htm
Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, Meier DE (2008) Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 168:1783–1790
Muench U, Simon M, Guerbaai R-A, de Pietro C, Zeller A, Kressig RW, Zúñiga F (2019) Preventable hospitalizations from ambulatory care sensitive conditions in nursing homes: evidence from Switzerland. Int J Public Health 64:1273–1281. https://doi.org/10.1007/s00038-019-01294-1
Panczak R, Luta X, Maessen M, Stuck AE, Berlin C, Schmidlin K, Reich O, von Wyl V, Goodman DC, Egger M, Zwahlen M, Clough-Gorr KM (2017) Regional variation of cost of care in the last 12 months of life in Switzerland: small-area analysis using insurance claims data. Med Care 55:155–163. https://doi.org/10.1097/MLR.0000000000000634
Polder JJ, Barendregt JJ, van Oers H (2006) Health care costs in the last year of life–the Dutch experience. Soc Sci Med (1982) 63:1720–1731
Pyenson B, Connor S, Fitch K, Kinzbrunner B (2004) Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manag 28:200–210. https://doi.org/10.1016/j.jpainsymman.2004.05.003
Reich O, Signorell A, Busato A (2013) Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data. BMC Health Serv Res 13:116
Schmid M, Zellweger U, Bosshard G, Bopp M (2016) Medical end-of-life decisions in Switzerland 2001 and 2013: Who is involved and how does the decision-making capacity of the patient impact? Swiss Med Wkly 146:w14307. https://doi.org/10.4414/smw.2016.14307
Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM, Corcoran CP, Haas JS (2008) Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol Off J Am Soc Clin Oncol 26:5671–5678. https://doi.org/10.1200/JCO.2008.16.3956
Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow H-H, Hovilehto S, Ledoux D, Lippert A, Maia P, Phelan D, Schobersberger W, Wennberg E, Woodcock T (2003) End-of-life practices in European intensive care units: the Ethicus study. JAMA 290:790–797. https://doi.org/10.1001/jama.290.6.790
Torbica A, Tarricone R, Drummond M (2018) Does the approach to economic evaluation in health care depend on culture, values, and institutional context? Eur J Health Econ 19:769–774. https://doi.org/10.1007/s10198-017-0943-1
van den Heede K, van de Voorde C (2016) Interventions to reduce emergency department utilisation: A review of reviews. Health Policy. https://doi.org/10.1016/j.healthpol.2016.10.002
Wang J, Schmid M (2007) Regional differences in health literacy in Switzerland, University of Zürich
Weissman JS, Cooper Z, Hyder JA, Lipsitz S, Jiang W, Zinner MJ, Prigerson HG (2016) End-of-life care intensity for physicians, lawyers, and the general population. JAMA 315:303–305. https://doi.org/10.1001/jama.2015.17408
Yarnell CJ, Fu L, Manuel D, Tanuseputro P, Stukel T, Pinto R, Scales DC, Laupacis A, Fowler RA (2017) Association between immigrant status and end-of-life care in Ontario, Canada. JAMA 318:1479–1488. https://doi.org/10.1001/jama.2017.14418
Acknowledgements
We are grateful for the opportunity to use the data on the final cause of death provided by the Swiss Federal Statistical Office. The authors also thank Sonja Wehrle and Mikaël Thomas for their helpful support in coding inpatient treatments and Annette Jamieson for her critical review of the manuscript.
Funding
Helsana Group provided support in the form of salaries for authors [CB, RR, AS, OR, EB] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
According to the national ethical and legal regulation (article 22 of the Swiss data protection law), ethical approval was not needed, as this study is retrospective and based on anonymized routine administrative healthcare claims data. Furthermore, a formal request was sent to the Ethics committee Kantonale Ethikkommission Zürich in the Canton of Zurich. According to this committee, no further ethics approval was needed as the study falls outside the scope of the Swiss Federal Act on Research involving Human Beings (Human Research Act).
Informed consent
Informed consent was not needed as this retrospective study used routinely collected data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bähler, C., Rapold, R., Signorell, A. et al. Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data. Int J Public Health 65, 969–979 (2020). https://doi.org/10.1007/s00038-020-01428-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-020-01428-w